Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks

DRUG2 trials

Sponsors

Bausch Health Americas, Inc.

Conditions

Chronic Hepatitis C

Phase 3

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

CompletedNCT00086541

Bausch Health Americas, Inc.Chronic Hepatitis C

Start: 2004-06-30End: 2007-01-31Updated: 2019-11-25

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

CompletedNCT00162734

Bausch Health Americas, Inc.Chronic Hepatitis C

Start: 2005-02-28End: 2007-06-30Updated: 2012-06-22